These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1586622)

  • 1. Antitumor activity of 1,4-bis (2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis Maleate) in M5076 and its subline resistant to cyclophosphamide M5/CTX.
    Tagliabue G; Filippeschi S; Hendricks H; D'Incalci M
    Ann Oncol; 1992 Mar; 3(3):233-6. PubMed ID: 1586622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate).
    Broggini M; Hartley JA; Mattes WB; Ponti M; Kohn KW; D'Incalci M
    Br J Cancer; 1990 Feb; 61(2):285-9. PubMed ID: 2393411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
    D'Incalci M; Torti L; Damia G; Erba E; Morasca L; Garattini S
    Cancer Res; 1983 Dec; 43(12 Pt 1):5674-80. PubMed ID: 6357429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent administration of Dabis Maleate, a phase I study.
    Verweij J; Planting AS; de Boer M; van der Burg ME; Stoter G
    Ann Oncol; 1992 Mar; 3(3):241-2. PubMed ID: 1586625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel mouse reticular cell sarcoma M5076 subline resistant to cisplatin.
    Ferrari A; Damia G; Erba E; Rossi C; Mandelli R; D'Incalci M
    Int J Cancer; 1989 Jun; 43(6):1091-7. PubMed ID: 2659542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumoral activity of the oxazaphosphorine derivative, mafosfamide-cyclohexylamine salt (ASTA 7557) on a murine ovarian reticular cell sarcoma and its subline resistant to cyclophosphamide.
    Colombo T; Paolini A; Finazzi M; Scanziani E; Mandelli G; Donelli MG
    Tumori; 1986 Dec; 72(6):637-42. PubMed ID: 3544404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of DABIS maleate given once every 3 weeks.
    van der Burg ME; Planting AS; Stoter G; McDaniel C; Vecht CJ; Verweij J
    Eur J Cancer; 1991; 27(12):1635-7. PubMed ID: 1782074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin.
    Belvedere G; Imperatori L; Damia G; Tagliabue G; Meijer C; de Vries EG; D'Incalci M
    Eur J Cancer; 1996 Oct; 32A(11):2011-8. PubMed ID: 8943689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
    Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic agents LXIV: 1,4-Bis(2'-chloroethyl)-1,4-diazabicyclo[2.2.1]heptane dihydrogen dimaleate.
    Pettit GR; Gieschen DP; Pettit WE
    J Pharm Sci; 1979 Dec; 68(12):1539-42. PubMed ID: 529047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
    Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
    Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.
    Damia G; Tagliabue G; Zucchetti M; Davoli E; Sessa C; Cavalli F; D'Incalci M
    Cancer Chemother Pharmacol; 1992; 30(6):459-64. PubMed ID: 1394802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of FCE 26644 a new growth-factor complexing molecule.
    Sola F; Farao M; Pesenti E; Marsiglio A; Mongelli N; Grandi M
    Cancer Chemother Pharmacol; 1995; 36(3):217-22. PubMed ID: 7781141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedule-dependent effectiveness of ADM and multiple cycles of DDP on a murine reticulum sarcoma.
    Leonetti C; Zupi G; Calabresi F; Greco C
    Anticancer Res; 1990; 10(1):45-8. PubMed ID: 2185688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro.
    Yi SN; Wass J; Vincent P; Iland H
    Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.
    Gerhartz HH; Liss E; Schmidt H
    J Cancer Res Clin Oncol; 1979 Jul; 94(3):257-63. PubMed ID: 479265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of the new minor groove alkylator tallimustine and melphalan.
    Tagliabue G; Filippini C; Ubezio P; D'Incalci M
    Eur J Cancer; 1997 Feb; 33(2):284-7. PubMed ID: 9135501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis-diamminedichloroplatinum sensitivity of murine reticulum sarcoma cells in primary culture and after in vitro passages.
    Balconi G; Damia G; Morali F; Marzola M; Tagliabue G; Erba E; D'Incalci M
    In Vitro Cell Dev Biol Anim; 1993 Aug; 29A(8):617-9. PubMed ID: 8376309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.